ClinicalTrials.Veeva

Menu

Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER)

D

Dr Sze-Yuan Ooi

Status

Unknown

Conditions

COVID

Treatments

Device: TCC-COVID mHealth solution

Study type

Interventional

Funder types

Other

Identifiers

NCT04399109
PID00770

Details and patient eligibility

About

This is a multi-site, prospective, non-randomised trial assessing the implementation of a smartphone application-based model of care for patients with COVID-19 infection managed in community isolation. We will recruit 2000 COVID +ve patients aged 18 years and over who are managed at home. The objective will be to describe the rates of avoidable presentations to ED and 30 day all case mortality per diagnosed COVID-19 case and to compare these to a propensity matched and synthetic control group.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age greater or equal to 18 years

  2. Able to provide informed consent

  3. Proven diagnosis of COVID-19 based on positive virology testing

  4. Patients who are being managed at home OR those who are being discharged from hospital for ongoing home-based care in isolation.

  5. Access to a smartphone or device that is compatible with the TCC-COVID app

    • Any iPhone or iPad running iOS 9 or above (essentially any iPhone 5 or above)
    • Any Android phone that is operating Android 7.0 or above
  6. Speaks adequate English

Exclusion criteria

  1. Patient meets clinical criteria for hospital-based care.

  2. Inability to use the TCC-COVID app and pulse oximeter due to reasons including but not limited to:

    • Cognitive impairment
    • Impaired dexterity
    • Visual impairment
    • Language barrier
  3. Patient residing outside the SESLHD catchment area during their period of isolation

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,000 participants in 2 patient groups

TCC-COVID mHealth solution
Active Comparator group
Description:
TCC-COVID is an app-based model of care which includes a smartphone app and a pulse oximeter that measures oxygen saturation, pulse rate and collects symptoms, connected to a back-end clinical database with inbuilt data analytics.
Treatment:
Device: TCC-COVID mHealth solution
Control
No Intervention group
Description:
Propensity matched and synthetic control groups will be utilised from another local health district not participating in the ReCOVER study. The control group will not be actively recruited at the same time as the intervention. The control group will be matched via data linkage at the completion of the trial. However, it is not a historical control, as the control standard of care treatment will be provided simultaneously as our intervention

Trial contacts and locations

3

Loading...

Central trial contact

Sze-Yuan Ooi; Nigel Lovell

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems